Fundraising Fox

Oxford Science Enterprises

Venture capital

Oxford · Pre-Seed–Growth

Fox Verdict
Sign up to see your fit

Investment thesis

Oxford Science Enterprises identifies breakthrough scientific research from leading academic institutions and commercializes it into venture-scale companies. The firm leverages deep scientific expertise, patient capital, and a proven venture-building operating model to de-risk scientific innovation and deliver strong returns. Their strategy focuses on world-class research with significant market potential across deeptech, life sciences, and physical sciences sectors.

Source: firm website, verified Jul 21, 2026.

Stage
Pre-Seed–Growth
HQ
Oxford, GB
Leads rounds
Leads
Instruments
Equity
Founded
2014
AUM
$1.1B
Tracked investments
82

Investments · showing 60 of 82

founders shown can be your intro path
Acionna Therapeutics
Alethio Therapeutics

Redefining treatment of incurable blood cancers by targeting the cells that drive them.

Allos
Alloyed
Alveogene
Amber Therapeutics
Archangel Lightworks
Ascension
Barinthus Biotherapeutics
Base Genomics
Beacon Therapeutics
BibliU
Caristo Diagnostics
Caudal Energy
Circadian Therapeutics
Credo Therapies
Dark Blue Therapeutics
Densix
DiffBlue
DJS Antibodies
EndLyz Therapeutics
Evolito
Evox Therapeutics
First Light Fusion
Fluorok
Fractile
Genomics
Grey Wolf Therapeutics
Ground Truth Labs
HEXR
Iota Sciences
ISOgenix
Kesmalea
Kneu Health
Latent Logic
Living Optics
Marley Health
MatchBio
Mind Foundry
MiroBio
Mixergy
Moa Technology
Mode Labs
Natcap
NavLive
Nucleome Therapeutics
Oath Surgical
Odqa Renewable Energy Technologies
OMass Therapeutics
Opsydia
Orbit Discovery
Orca Computing
ORFonyx
Osler Diagnostics
Oxford Endovascular
Oxford Flow
Oxford Ionics

Developing quantum computing technology.

Oxford Nanoimaging
Oxford Quantum Circuits
Oxford Semantic Technologies

Frequently asked questions

What stage does Oxford Science Enterprises invest at?
Oxford Science Enterprises invests at the Pre-Seed, Seed, Series A, Series B, Series C, Growth stages.
What sectors does Oxford Science Enterprises focus on?
Oxford Science Enterprises focuses on AgTech, AI & Machine Learning, Biotech, Cleantech, Deep Tech, Quantum Computing, Sector Agnostic.
Where is Oxford Science Enterprises located?
Oxford Science Enterprises is headquartered in Oxford, GB.
Does Oxford Science Enterprises lead rounds?
Yes, Oxford Science Enterprises leads investment rounds.

Images

Oxford Science Enterprises photo

Similar investors

DCVC (Data Collective)

DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.

Innovestor Ventures

Innovestor is a Finnish investment manager that operates across venture capital, real estate, and energy storage sectors. The firm invests in early-stage technology and life science startups, energy-efficient commercial real estate, and battery storage and solar solutions. Innovestor also provides corporate venturing advisory services.

B Capital Group

B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.

Honda Innovations Silicon Valley

Honda Innovations is the corporate venture capital arm of Honda, launched in 2005 to identify and invest in transformative technologies. Operating globally through Honda Xcelerator Ventures, the firm engages innovators across all stages to build the carbon-neutral future of mobility through strategic partnerships, co-development, and direct investment.

SOSV

SOSV is the world's most active deep tech venture capital firm, investing in founders at pre-seed inception across a global network of facilities and offices. The firm partners with founders to build companies with significant impact on human and planetary health.

$550K

Featured in lists